Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Association Between Anti-diabetic Agents and Clinical Outcomes of COVID-19 in Patients with Diabetes: A Systematic Review and Meta-Analysis
Tiantian Han, Shaodi Ma, Chenyu Sun, et al.
Archives of Medical Research (2021) Vol. 53, Iss. 2, pp. 186-195
Open Access | Times Cited: 50

Showing 1-25 of 50 citing articles:

Endothelial dysfunction in COVID-19: an overview of evidence, biomarkers, mechanisms and potential therapies
Suowen Xu, Iqra Ilyas, Jianping Weng
Acta Pharmacologica Sinica (2022) Vol. 44, Iss. 4, pp. 695-709
Open Access | Times Cited: 283
Diabetes and the COVID-19 pandemic
Kamlesh Khunti, Jonathan Valabhji, Shivani Misra
Diabetologia (2022) Vol. 66, Iss. 2, pp. 255-266
Open Access | Times Cited: 78
Preadmission use of antidiabetic medications and mortality among patients with COVID-19 having type 2 diabetes: A meta-analysis
Nam Nhat Nguyen, Dung Si Ho, Hung Song Nguyen, et al.
Metabolism (2022) Vol. 131, pp. 155196-155196
Open Access | Times Cited: 69
Improvement of glycemic control and reduction of major cardiovascular events in 18 cardiovascular outcome trials: an updated meta-regression
Maria Ida Maiorino, Miriam Longo, Lorenzo Scappaticcio, et al.
Cardiovascular Diabetology (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 57
The Association Between Antidiabetic Agents and Clinical Outcomes of COVID-19 Patients With Diabetes: A Bayesian Network Meta-Analysis
Yidan Chen, Xingfei Lv, Sang Lin, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 34
DPP-4 Inhibitors as a savior for COVID-19 patients with diabetes
Snehasish Nag, Samanwita Mandal, Oindrila Mukherjee, et al.
Future Virology (2023) Vol. 18, Iss. 5, pp. 321-333
Open Access | Times Cited: 20
Analysis of All-Cause Hospitalization and Death Among Nonhospitalized Patients With Type 2 Diabetes and SARS-CoV-2 Infection Treated With Molnupiravir or Nirmatrelvir-Ritonavir During the Omicron Wave in Hong Kong
David Tak Wai Lui, Matthew S. H. Chung, Eric H. Y. Lau, et al.
JAMA Network Open (2023) Vol. 6, Iss. 5, pp. e2314393-e2314393
Open Access | Times Cited: 18
Metformin use is associated with a decrease in the risk of hospitalization and mortality in COVID‐19 patients with diabetes: A population‐based study in Lombardy
Luisa Ojeda‐Fernández, Andreana Foresta, Giulia Macaluso, et al.
Diabetes Obesity and Metabolism (2022) Vol. 24, Iss. 5, pp. 891-898
Closed Access | Times Cited: 22
Pre-admission use of sodium glucose transporter-2 inhibitor (SGLT-2i) may significantly improves Covid-19 outcomes in patients with diabetes: A systematic review, meta-analysis, and meta-regression
Hikmat Permana, Theo Audi Yanto, Timotius Ivan Hariyanto
Diabetes Research and Clinical Practice (2022) Vol. 195, pp. 110205-110205
Open Access | Times Cited: 20
Metformin use in patients hospitalized with COVID-19: lower inflammation, oxidative stress, and thrombotic risk markers and better clinical outcomes
Abira Usman, Kevin P. Bliden, Alastair Cho, et al.
Journal of Thrombosis and Thrombolysis (2022) Vol. 53, Iss. 2, pp. 363-371
Open Access | Times Cited: 19
Risk factors for COVID-19 case fatality rate in people with type 1 and type 2 diabetes mellitus: A nationwide retrospective cohort study of 235,248 patients in the Russian Federation
Marina V. Shestakova, O. K. Vikulova, A. R. Elfimova, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 19
Effect of DPP4/CD26 expression on SARS‑CoV‑2 susceptibility, immune response, adenosine (derivatives m62A and CD) regulations on patients with cancer and healthy individuals
Jiaman Du, Jiewen Fu, Wenqian Zhang, et al.
International Journal of Oncology (2023) Vol. 62, Iss. 3
Open Access | Times Cited: 13
Antidiabetic agent use and clinical outcomes in patients with diabetes hospitalized for COVID-19: a systematic review and meta-analysis
Jordan N. Keels, Isabella R. McDonald, Christopher S. Lee, et al.
Frontiers in Endocrinology (2025) Vol. 15
Open Access
Association of anti-diabetic drugs and COVID-19 outcomes in patients with diabetes mellitus type 2 and cardiomyopathy
Jelena Dimnjaković, Tamara Buble, Pero Ivanko, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
The Effect of Antihyperglycemic Medications on COVID-19: A Meta-analysis and Systematic Review from Observational Studies
Zhi-Hui Song, Qiao-Ming Huang, Shan-Shan Xu, et al.
Therapeutic Innovation & Regulatory Science (2024) Vol. 58, Iss. 4, pp. 773-787
Closed Access | Times Cited: 3
SGLT2 Inhibitors in COVID-19: Umbrella Review, Meta-Analysis, and Bayesian Sensitivity Assessment
Vinay Suresh, Muhammad Aaqib Shamim, Victor Ghosh, et al.
Diseases (2025) Vol. 13, Iss. 3, pp. 67-67
Open Access
Dipeptidyl Peptidase-4 Inhibitors, Glucagon-like Peptide-1 Receptor Agonists, and Sodium-Glucose Cotransporter-2 Inhibitors and COVID-19 Outcomes
Andreana Foresta, Luisa Ojeda‐Fernández, Giulia Macaluso, et al.
Clinical Therapeutics (2023) Vol. 45, Iss. 4, pp. e115-e126
Open Access | Times Cited: 9
Is Metformin Use Associated with a More Favorable COVID-19 Course in People with Diabetes?
Giovanni Antonio Silverii, Carlo Fumagalli, Renzo Rozzini, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 7, pp. 1874-1874
Open Access | Times Cited: 3
A Brief Report on the Effect of Covid 19 Pandemic on Patients Undergoing Skin Graft Surgery in a Burns Hospital from March 2019 to March 2020
Hamidreza Alizadeh Otaghvar, Arian Karimi, Golnaz Mahmoudvand, et al.
Journal of Case Reports and Medical History (2022)
Open Access | Times Cited: 13
Analysis of risk factors for COVID-19-related fatal outcome in 337991 patients with type 1 and type 2 diabetes mellitus in 2020–2022 years: Russian nationwide retrospective study
Н. Г. Мокрышева, М. В. Шестакова, Olga Konstantinovna Vikulova, et al.
Diabetes Mellitus (2022) Vol. 25, Iss. 5, pp. 404-417
Open Access | Times Cited: 13
Potential use of sodium glucose co-transporter 2 inhibitors during acute illness: a systematic review based on COVID-19
Carmen Tisch, Eleni Xourgia, Aristomenis K. Exadaktylos, et al.
Endocrine (2024) Vol. 85, Iss. 2, pp. 660-675
Open Access | Times Cited: 2
Use of Novel Antidiabetic Agents in Patients with Type 2 Diabetes and COVID-19: A Critical Review
Djordje S. Popovic, Νικόλαος Παπάνας, Anca Pantea Stoian, et al.
Diabetes Therapy (2021) Vol. 12, Iss. 12, pp. 3037-3054
Open Access | Times Cited: 15
Effect of Antidiabetic Therapy on Clinical Outcomes of COVID-19 Patients With Type 2 Diabetes: A Systematic Review and Meta-Analysis
Kegang Zhan, Liuqi Weng, Qi Li, et al.
Annals of Pharmacotherapy (2022) Vol. 57, Iss. 7, pp. 776-786
Open Access | Times Cited: 9
Antidiabetic Drug Efficacy in Reduction of Mortality during the COVID-19 Pandemic
Daniel Gonikman, Dmitrijs Kustovs
Medicina (2023) Vol. 59, Iss. 10, pp. 1810-1810
Open Access | Times Cited: 5
Impact of the COVID-19 pandemic on antidiabetic drugs initiation in Sweden, an interrupted time series study
Nataliia Khanyk, Fredrik Nyberg, Björn Wettermark, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top